Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Sponsor: University Hospital Tuebingen
Summary
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
Official title: Treatment of Infections of the Cervix Uteri With High- and Low-risk Variants of the Human Papillomavirus Using Non-invasive Physical Plasma
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2023-12-27
Completion Date
2026-12
Last Updated
2026-01-26
Healthy Volunteers
No
Conditions
Interventions
Cold physical Plasma
The treatment is administered by either the supervising specialists or assistant doctors at the University Women's Hospital, under their supervision and authorization. It's important to note that the NIPP treatment is designed to be relatively brief, with a duration not exceeding 10-20 minutes.
Control group
A potential natural healing of the HPV infection will be anticipated
Locations (1)
University Hospital Tuebingen, Department of Women's Health
Tübingen, Germany